Article Details

Novartis says it overpaid Roche's Genentech nearly $210 million in a licensing deal—and it wants ...

Retrieved on: 2021-06-28 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Novartis says it overpaid Roche's Genentech nearly $210 million in a licensing deal—and it wants .... View article details on hiswai:

Excerpt

For years, Novartis said it dutifully shelled out tens of millions to Genentech as part of a patent licensing deal that dated back to 2005. Later, the Swiss ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up